Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Kexing Biopharm Co., Ltd.

Clinical trials sponsored by Kexing Biopharm Co., Ltd., explained in plain language.

Kexing Biopharm Co., Ltd. 688136 SSE

A Chinese biopharmaceutical company developing vaccines and biological products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 3 Not yet finished but already full! 1

New shot could shield breast cancer patients from Chemo's dangerous side effect

Prevention Ongoing

This phase 3 trial tests a long-acting injection called PEG-G-CSF to prevent severe neutropenia (dangerously low white blood cell counts) after chemotherapy in 250 women with breast cancer. Participants receive either the test drug or the already-approved Neulasta. The goal is to…

Phase: PHASE3 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Prevention

Last updated Jun 27, 2026 07:59 UTC